Green Spirit Requested Final Inspection of First Medicinal Cannabis Dispensary in Puerto Rico

SAN JUAN, Puerto Rico, Feb. 06, 2018 -- Green Spirit Industries Inc. (OTC Pink:GSRX) (“Green Spirit” or, the “Company”) announced today that it has requested final inspection of its medicinal cannabis dispensary located in Dorado, Puerto Rico by the Department of Health of Puerto Rico (the “DHPR”). The Company previously announced (Construction Completed at Dorado Dispensary) completion of construction of its first medical cannabis dispensary located in Dorado, about 15 miles west of San Juan, on the island’s northern coast. The Company is now in the process of staffing the location, and once the dispensary passes inspection and the DHPR issues the requisite Occupational License for Establishment, the Company will be ready to begin operations. 

The new medicinal cannabis dispensary is located at the Paseo del Plata Shopping Center, Building No. 3, P.R. 696, int. José Efrón Avenue, Dorado, Puerto Rico 00646. The Company believes the dispensary is a safe, secure and beautifully appointed space where patients will be afforded both private consultation and an extensive selection of medicinal cannabis products for purchase. Dorado is a popular tourist destination with a number of golf courses, beaches and luxury hotels, including Dorado Beach – A Ritz-Carlton Reserve, the Caribbean’s only 2017 Forbes Five-Star Hotel and Spa award winner. Dorado Beach East is one of the islands most sought-after luxury residential areas, and home to some of Puerto Rico’s most exclusive neighborhoods and multi-million dollar residences.

The Company anticipates completing construction at its other locations during the first quarter of 2018, with operations commencing thereafter upon receipt of the requisite operating permits from the DHPR. For more information about Green Spirit, visit the Company’s website at http://www.greenspiritrx.com/.

About Green Spirit Industries Inc.
Green Spirit Industries Inc. (OTC Pink:GSRX), together with its wholly-owned subsidiary, Project 1493, LLC, is in the business of acquiring, developing and operating medical cannabis dispensaries.

Forward-Looking Statements                                                                                                 
This press release contains forward-looking statements. Such statements include statements regarding our expectations, hopes, beliefs or intentions regarding the future, including but not limited to statements regarding our market, strategy, competition, development plans (including acquisitions and expansion), financing, revenues, operations, and compliance with applicable laws. Forward-looking statements involve certain risks and uncertainties, and actual results may differ materially from those discussed in any such statement. Factors that could cause actual results to differ materially from such forward-looking statements include the risks described in greater detail in the following paragraphs. All forward-looking statements in this document are made as of the date hereof, based on information available to us as of the date hereof, and we assume no obligation to update any forward-looking statement except where applicable law requires us to update these statements. Market data used throughout this prospectus is based on published third party reports or the good faith estimates of management, which estimates are based upon their review of internal surveys, independent industry publications and other publicly available information.

Contact:                                
Paul Gendreau
PGPR
[email protected]
678-807-7945